Charles Bennett to Thrombocythemia, Essential
This is a "connection" page, showing publications Charles Bennett has written about Thrombocythemia, Essential.
Connection Strength
0.157
-
Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers? Semin Hematol. 1999 Jan; 36(1 Suppl 2):26-9.
Score: 0.157